Department of Agriculture & U.S
Expect variation - the second time can feel stronger, weaker, or simply different
These interventions have been shown to improve glycemic control and body weight by enhancing glucose-dependent insulin secretion, decreasing glucagon secretion, delaying gastric emptying, reducing appetite, and modulating central pathways involved in satiety and energy intake (Radparvar and Agrawal, 2025
Understanding the Three Target Hormones How Retatrutide Engages the GLP-1 Receptor How Retatrutide Engages the GIP Receptor How Retatrutide Engages the Glucagon Receptor Why Balanced Triple Agonism Matters Molecular Structure and Modifications Pharmacokinetics: How Long Retatrutide Stays Active Downstream Signalling and Integrated Effects Clinical Evidence Base Retatrutide in Research Context Frequently Asked Questions Retatrutide Mechanism Quick Overview What Is Retatrutide (LY3437943)
This translated to a hazard ratio of 0.92, meeting the prespecified threshold for non-inferiority, though not superiority
This is one of the most exciting findings